Details of the presentations are as follows:

Poster Presentations

Poster Title: Characterization of Cognitive Domains in Individuals with MCI and AD Dementia with The Altoida Digital Neuro Signature (DNS)

Presenter: Alberto Ferrari, Ph.D., Biostatistician, Altoida

Poster Number: P0449* / #2273

Onsite Poster Board Number: 401

Poster Title: Evaluation of The Altoida Digital Neuro Signature (DNS) in Cognitively Normal and MCI Individuals with Hearing Loss - A Pilot Study

Presenter: Florencia Iulita, Ph.D., Head of Medical Strategy and Operations, Altoida

Poster Number: P0450* / #2128

Onsite Poster Board Number: 402

Poster category: A04.J. Imaging, Biomarkers, Diagnostics: Cognitive, Psychometric & Behavioral Tests, Digital Endpoints, Remote Testing

About Altoida, Inc.

Altoida is developing digital biomarkers of neurological disease with the power of augmented reality and machine learning all from a smart device. Our innovative AI-driven approach combines novel digital biomarkers with augmented reality to evaluate the brain while conducting immersive tasks. Altoida’s evidence-based platform is founded on more than 20 years of scientific research and published in multiple peer-reviewed papers. Altoida is based in Washington, DC. For more information, visit www.altoida.com or follow @Altoida on Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230320005527/en/